Ze-Rui Zhao

Department of Thoracic Surgery, Sun Yat-sen University Cancer Center

Affiliated withSun Yat-sen University Cancer Center

Research Area

Biography

Ze-Rui Zhao has not added Biography.
If you are Ze-Rui Zhao and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2026

Other Publications

Article	Year
Mutation abundance affects the efficacy of EGFR tyrosine kinase inhibitor readministration in non-small-cell lung cancer with acquired resistance. Medical oncology (Northwood, London, England)\| PubMed ID: 24338271	2014
Readministration of EGFR tyrosine kinase inhibitor in non-small cell lung cancer patients after initial failure, what affects its efficacy? Scientific reports\| PubMed ID: 25104233	2014
Prognostic impact of pattern-based grading system by the new IASLC/ATS/ERS classification in Asian patients with stage I lung adenocarcinoma. Lung cancer (Amsterdam, Netherlands)\| PubMed ID: 26547801	2015
Prognostic Effect of TP53 and PKD Co-Mutations in Patients with Resected Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma. Annals of surgical oncology\| PubMed ID: 30820786	2019
Mutation Profile of Resected -Mutated Lung Adenocarcinoma by Next-Generation Sequencing. The oncologist\| PubMed ID: 30872465	2019
Devising the guidelines: the techniques of pulmonary nodule localization in uniportal video-assisted thoracic surgery-hybrid operating room in the future. Journal of thoracic disease\| PubMed ID: 31637041	2019
Novel prognostic model for stratifying survival in stage I lung adenocarcinoma patients. Journal of cancer research and clinical oncology\| PubMed ID: 31884561	2020
Pulmonary Metastasectomy in Patients with Lung Metastases from Nasopharyngeal Carcinoma. Annals of surgical oncology\| PubMed ID: 33492543	2021
ASO Author Reflections: Pulmonary Metastasectomy in Patients with Lung Metastases from Nasopharyngeal Carcinoma. Annals of surgical oncology\| PubMed ID: 33586071	2021
Phase 2 trial of neoadjuvant toripalimab with chemotherapy for resectable stage III non-small-cell lung cancer. Oncoimmunology\| PubMed ID: 34712513	2021
A Novel Inflammatory-Related Gene Signature Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma. Frontiers in genetics\| PubMed ID: 35069695	2021
An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Squamous Carcinoma. Frontiers in cell and developmental biology\| PubMed ID: 35300428	2022
Different Immune Patterns between Primary Tumor and Lymph Node in Non-Small-Cell Lung Cancer: Potential Impact on Neoadjuvant Immunotherapy. Journal of immunology research\| PubMed ID: 35528615	2022
Integrative Analysis of Bioinformatics and Machine Learning Algorithms Identifies a Novel Diagnostic Model Based on Costimulatory Molecule for Predicting Immune Microenvironment Status in Lu... The American journal of pathology\| PubMed ID: 35948079	2022
Response of primary tumor and lymph node in non-small cell lung cancer after neoadjuvant immunotherapy: a pooled analysis. Journal for immunotherapy of cancer\| PubMed ID: 36109085	2022
Neoadjuvant Immunotherapy in Oncogene-Positive Non-Small Cell Lung Cancer: A Multicenter Study. The Annals of thoracic surgery\| PubMed ID: 36521526	2023
Prognostic value of L4 lymph node dissection during video-assisted thoracoscopic surgery in patients with left-sided non-small cell lung cancer: a single-center, retrospective cohort study. Translational lung cancer research\| PubMed ID: 37057116	2023
Pan-Immune-Inflammatory Value in Patients with Non-Small-Cell Lung Cancer Undergoing Neoadjuvant Immunochemotherapy. Journal of inflammation research\| PubMed ID: 37576157	2023
Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm,... The Lancet. Respiratory medicine\| PubMed ID: 39305910	2024
Minimally invasive autologous pericardial patch reconstruction of the pulmonary artery for locally advanced lung cancer following neoadjuvant treatment. Surgery today\| PubMed ID: 39312009	2025
Adjuvant immunotherapy does not improve survival in non-small cell lung cancer with major/complete pathologic response after induction immunotherapy. The Journal of thoracic and cardiovascular surgery\| PubMed ID: 39617319	2025
TLS and immune cell profiling: immunomodulatory effects of immunochemotherapy on tumor microenvironment in resectable stage III NSCLC. Frontiers in immunology\| PubMed ID: 39726591	2024
Extended Sleeve Lobectomy After Neoadjuvant Immunochemotherapy for Centrally Located Non-small Cell Lung Cancer. The Annals of thoracic surgery\| PubMed ID: 40216350	2025
Prognosis and relapse patterns in patients with non-small cell lung cancer with pathologic complete response after neoadjuvant immunochemotherapy. Journal of thoracic disease\| PubMed ID: 40400964	2025
Reframing Extended Sleeve Lobectomy After Immunochemotherapy: From Selection Bias to Identifying True Beneficiaries. The Annals of thoracic surgery\| PubMed ID: 41407137	2025
Lobectomy-first versus lymphadenectomy-first on long-term survival for operable non-small cell lung cancer: protocol of LOFTY trial. Trials\| PubMed ID: 41462323	2025
Surgical techniques for thoracoscopic secondary carinal reconstruction with stepwise barbed sutures. General thoracic and cardiovascular surgery\| PubMed ID: 41511726	2026
Fibrin sealant for prophylaxis of cervical anastomotic leakage after McKeown esophagectomy for esophageal or esophagogastric junction cancer (PLACE030): a Phase III multicenter randomized cl... International journal of surgery (London, England)\| PubMed ID: 41677267	2026
Comparison of Two Dye Marking Methods for Preoperative Localization of Pulmonary Nodules Guided by Electromagnetic Navigation Bronchoscopy. Thoracic cancer\| PubMed ID: 41744188	2026